3U2S image
Entry Detail
PDB ID:
3U2S
Keywords:
Title:
Crystal Structure of PG9 Fab in Complex with V1V2 Region from HIV-1 strain ZM109
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2011-10-04
Release Date:
2011-11-30
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Envelope glycoprotein gp120
Chain IDs:C (auth: G), F (auth: C)
Chain Length:124
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:PG9 heavy chain
Chain IDs:A (auth: H), D (auth: A)
Chain Length:248
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:PG9 light chain
Chain IDs:B (auth: L), E (auth: B)
Chain Length:216
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN F ASN GLYCOSYLATION SITE
PCA A GLN PYROGLUTAMIC ACID
TYS A TYR O-SULFO-L-TYROSINE
Primary Citation

Abstact

Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded β-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.

Legend

Protein

Chemical

Disease

Primary Citation of related structures